載入...
Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model
Spironolactone and furosemide, which are used to treat ascites associated with decompensated cirrhosis, are ineffective in treating refractory ascites. Hence, combination therapy with tolvaptan, a vasopressin V2 receptor antagonist, has been approved in Japan. Tolvaptan monotherapy and combination t...
Na minha lista:
| 發表在: | J Clin Biochem Nutr |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
the Society for Free Radical Research Japan
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5525014/ https://ncbi.nlm.nih.gov/pubmed/28751810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.16-122 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|